Modified Functional Magnetic Stimulation Treatment for Constipation Improvement

NCT ID: NCT01452386

Last Updated: 2016-11-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2011-06-30

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To prove the modify functional magnetic stimulation could improve constipation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Permission: Any agent without effecting gastrointestinal motility or defecation is allowed.
2. Inhibition: From test day to the next day(48 hours),it's not allowed to take any medication treatment which might affect digestive system or excretory system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Constipation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Constipation Stimulation Treatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental Group

No interventions assigned to this group

Control Group

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who age between 20\~60 years old and have suffered from chronic constipation for more than 6 months will be enrolled in this study.

Exclusion Criteria

* Patients with implantation chip of brain
* Patients with implantation of pacemaker
* Patients with heart transplantation
* Patients are embedded electronic and Life support products.
* People who have be implanted metal、electronic devices、artificial joints or fixator.
* Patients with hemiplegia
* Patients with peripheral neuritis
* Patients with Prostate abnormalities
* Patients with Pregnancy
* Patients with Fever
* Patients with Injure
* Patients with Heart disease
* Patients with Consciousness disturbance
* Patients with Organic constipation
* Patients with Kidney stone
* Patients with Ureteric calculus
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taipei Medical University WanFang Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fat-Moon Suk

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fat-Moon Suk

Role: PRINCIPAL_INVESTIGATOR

Taipei Medical University WanFang Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Taipei Medical University - WanFang Hospital

Taipei, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

99081

Identifier Type: -

Identifier Source: org_study_id